The Division of Endocrinology, Metabolism & Lipid Research in the Department of Medicine has received a $2.75 million gift through the Anita Palmer Corbin Trust to establish the Anita Palmer Corbin Diabetes Research Endowed Fund. The fund augments a spendable fund to support diabetes research in the division that was previously created by Corbin, who […]
Congratulations to Irfan Lodhi, PhD; Jeffrey R. Millman, PhD; Maria S. Remedi, PhD; and Julie M. Silverstein, MD of Washington University’s Division of Endocrinology, Metabolism and Lipid Research on achieving full professorship in their scientific and medical careers! The doctors were proudly joined by their colleagues on Thursday, August 22 to honor and celebrate their […]
On March 5, Jeffrey Millman, PhD was featured on The Sugar Science’s Ask the Expert webinar series, hosted on YouTube. The episode was titled “Unraveling Cellular Complexity in Stem Cell-Derived Islet Identity through Single-Cell Sequencing.” In the webinar, Dr. Millman gave an overview of using stem cell-derived islets in diabetes cellular therapy, and a comparative […]
Earlier this year, Jeffrey Millman, PhD received sub-award funding from JDRF to support his lab’s extensive research in advancing diabetes cell replacement therapy. The scarcity of pancreas donors has severely limited the supply of insulin-producing islets for clinical transplantation, prompting the exploration of alternative sources. Dr. Millman has pioneered approaches to generate lab-grown islets from […]
On May 4, Nathaniel Hogrebe, PhD; Matthew Ishahak, PhD; and Jeffrey Millman, PhD had their review titled “Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes,” published in Cell Stem Cell. In diabetes treatment, there is great potential for islet-like endocrine clusters from human pluripotent stem cells (hPSCs) to provide a limitless […]
On September 22, Jeffrey R. Millman, PhD and Fumihiko Urano, MD, PhD, along with colleagues, had their research titled, “Multidimensional analysis and therapeutic development using patient iPSC–derived disease models of Wolfram syndrome,” published in “JCI Insight.” “Wolfram syndrome is a rare genetic disorder largely caused by pathogenic variants in the WFS1 gene and manifested by diabetes mellitus, […]
On July 17, Jeffrey R. Millman, PhD was featured in AP News’ article titled, “High-flying experiment: Do stem cells grow better in space?” As scientists see great promise in stem cell research, “researcher Dhruv Sareen’s own stem cells are now orbiting the Earth. The mission? To test whether they’ll grow better in zero gravity.” […]
On March 16, Jeffrey R. Millman, PhD and collaborators had their research titled “Differential Function and Maturation of Human Stem Cell-Derived Islets After Transplantation,” published in issue 3 of “Stem Cells Translational Medicine.” It is evident that cell replacement therapy is a potential treatment for patients with diabetes. One possible renewable source of replacement cells are stem-cell […]